HeTOP

QD442 disease mongering(Q-code)

Show all languages

Origin ID

QD442

Preferred Label

disease mongering

fabrication de maladie

Obsolete resource

false

Category label

Disease mongering

Fabrication de maladie

Q-Code supplementary keywords

direct-to-consumer advertising (DTCA)

direct-to-consumer drug product advertising (DTCPA)

disease promotion

selling sickness

Q-Code acronym

DTCA

DTCPA

Q-Code scope note

the selling of sickness that widens the boundaries of illness in order to grow markets for those who sell and deliver treatments. (Moynihan et al., 2008)

création de maladies par élargissement de leurs limites afin de faire croître les marchés pour ceux qui vendent et distribuent des traitements. (Moynihan et al., 2008)

Définition CISMeF

L’expression « façonnage de maladie » (ou disease mongering pour les anglophones) désigne (plutôt péjorativement) la pratique de firmes pharmaceutiques consistant à inventer des maladies (ou à élargir les frontières diagnostiques (descriptions nosographiques) de maladies ou états existants et traitables comme la mauvaise haleine, le surpoids, la « bedaine », la calvitie masculine, la cholestérolémie, l’hypertension artérielle, le ronflement, la timidité, certains troubles de l'érection, l’ostéoporose, la scoliose, voire certaines phobies sociales, et états mentaux tels que le troubles de l'attention, syndrome d'hyperactivité avec déficit de l'attention, dépression et troubles bipolaires), tout en promouvant - généralement avec d’importants moyens de communication, voire de manière agressive - une « sensibilisation » du grand public à ces nouvelles maladies (source https://fr.wikipedia.org/wiki/Disease_mongering).

Q-Code conceptual content

direct-to-consumer product advertising (DTCPA) ; DTCPA can be defined as an effort (usually via popular media) made by a pharmaceutical company to promote its prescription products directly to patients (Ventola CL 2011)

Disease mongering ; is a pejorative term for the practice of widening the diagnostic boundaries of illnesses, and promoting public awareness of such, in order to expand the markets for those who sell and deliver treatments, which may include pharmaceutical companies, physicians, and other professional or consumer organizations.(Wikipedia)

Disease mongering ; is the selling of sickness that widens the boundaries of illness in order to grow markets for those who sell and deliver treatments.(Moynihan & all 2008)

CISMeF synonym

façonnage de maladie

Bibliographic link

http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0050106

http://www.aafp.org/afp/2009/1015/p775.html

http://www.ijhpm.com/article_3164_629.html

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278148/

http://www.ncbi.nlm.nih.gov/pubmed/17384871

http://www.ncbi.nlm.nih.gov/pubmed/19122961

http://www.ncbi.nlm.nih.gov/pubmed/21319723

http://www.ploscollections.org/article/browseIssue.action?issue=info:doi/10.1371/issue.pcol.v07.i02

https://www.nejm.org/doi/full/10.1056/NEJMsa065779

Citation

Shankar PR, Subish P. Disease mongering. Singapore medical journal. 2007; 48(4): 275-80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17384871

ur Rehman T, Jawaid A. Disease mongering: the role of medical journals. Singapore medical journal. 2008; 49(12): 1057-8; author reply 1058-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19122961

Vance MA. Disease mongering and the fear of pandemic influenza. International journal of health services : planning, administration, evaluation. 2011; 41(1): 95-115. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21319723

BabelNet link

bn:02354871n

Dbpedia link

http://dbpedia.org/page/Disease_mongering